In conclusion, our current study demonstrates a novel mechanism of suppression of alternative NF-κB by IFNγ that selectively promotes the expression of CTL-attracting chemokines and recruitment of CTLs by tumor-resident myeloid cells without the recruitment of Tregs. The gene discussed is IFNG; the disease is neoplasm.